Kinaset Therapeutics Funding: $150M Raised, Series B (2026)
Kinaset Therapeutics is based in Medfield, MA. It has raised $150M in total funding. Latest round: Series B.
Kinaset Therapeutics funding overview
Kinaset Therapeutics is based in Medfield, MA. Kinaset Therapeutics has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2026. The round record for Kinaset Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include RA Capital Management, Forge Life Science Partners, EQT Life Sciences, Vivo Capital, Schroders Capital, Willett Advisors and 5 others. 11 distinct backers are named across the disclosed rounds.
Kinaset Therapeutics at a glance
Total raised
$150M
Latest round
Series B
Latest round date
January 2026
Headquarters
Medfield, MA
Notable investors
RA Capital Management, Forge Life Science Partners, EQT Life Sciences, Vivo Capital, Schroders Capital, Willett Advisors, Pictet Alternative Advisors, Sixty Degree Capital
Frequently asked about Kinaset Therapeutics funding
How much has Kinaset Therapeutics raised?
Kinaset Therapeutics has raised $150M in total disclosed funding across the rounds on record.
Who has invested in Kinaset Therapeutics?
RA Capital Management, Forge Life Science Partners, EQT Life Sciences, Vivo Capital, Schroders Capital, Willett Advisors are named among the investors backing Kinaset Therapeutics.
What was the latest Kinaset Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2026.
Where is Kinaset Therapeutics based?
Kinaset Therapeutics is based in Medfield, MA.
When did Kinaset Therapeutics last raise?
The last disclosed Kinaset Therapeutics round closed in January 2026 at Series B.
Totals shown for Kinaset Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Medfield and the investors behind them below.
